TAT-Modified Martentoxin Displays Intravenous Antiseizure Activities.

antiseizure blood–brain barrier cell-penetrating peptide TAT intravenous injection martentoxin

Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
19 Dec 2023
Historique:
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

Epilepsy is a chronic disease of brain dysfunction, which arises from imbalance between excitatory and inhibitory activities in neural circuits. Previously, we reported that peptide Martentoxin (MarTX), from scorpion Buthus martensii Karsch, displayed antiseizure activities by specifically inhibiting BK(α + β4) channel currents. Injection of MarTX into the hippocampal region of mice significantly alleviated convulsive seizures. However, intravenous injection of MarTX had no antiepileptic efficacy due to the blood-brain barrier (BBB). To address this, here, we designed cell-penetrating peptide TAT-modified MarTX, in which the linker containing three glycines was put between TAT and the N-terminus of MarTX (forming MTX-N-TAT) or between TAT and the C-terminus of MarTX (forming MTX-C-TAT), respectively. We prepared them in a large amount through

Identifiants

pubmed: 38112732
doi: 10.1021/acschemneuro.3c00744
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Huan Liu (H)

School of pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.

Dongxiao Qu (D)

Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.

Yunzhu Cao (Y)

State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
Nanjing Fenglin Biotechnology Co., 2 Taixi Road, Pukou District, Nanjing 210031, China.

Haiting Li (H)

State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
Center for Supramolecular Chemistry and Catalysis, Department of Chemistry, College of Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China.

Xiaoyu Wu (X)

Center for Supramolecular Chemistry and Catalysis, Department of Chemistry, College of Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China.

Yudan Zhu (Y)

Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
School of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Jie Tao (J)

Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.

Yiming Li (Y)

School of pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Chunyang Cao (C)

State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.

Classifications MeSH